Trends in end-stage renal disease
- 1 July 2000
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 108 (1), 124-142
- https://doi.org/10.3810/pgm.2000.07.1152
Abstract
ESRD is always fatal unless recognized and treated appropriately. In the United States, the incidence of ESRD is increasing. Fortunately, both mortality among dialysis patients and the rate at which ESRD has been increasing over the past decade are declining. Obviously, the primary goal should be prevention of ESRD. Aggressive treatment of hypertension and hyperglycemia is likely to reduce the incidence of ESRD. Screening for diabetes and hypertension may be a fruitful approach to reduction in ESRD rates, because many patients present with renal failure after prolonged periods of undiagnosed hypertension or type 2 diabetes.Keywords
This publication has 11 references indexed in Scilit:
- HospitalizationAmerican Journal of Kidney Diseases, 1999
- Renal transplantation: Access and outcomesAmerican Journal of Kidney Diseases, 1999
- Causes of deathAmerican Journal of Kidney Diseases, 1999
- Patient mortality and survivalAmerican Journal of Kidney Diseases, 1999
- Treatment modalities for ESRD patientsAmerican Journal of Kidney Diseases, 1999
- Incidence and prevalence of ESRDAmerican Journal of Kidney Diseases, 1999
- Mortality in End-Stage Renal DiseaseJournal of the American Society of Nephrology, 1999
- Lessons from the hemodialysis (HEMO) Study: An improved measure of the actual hemodialysis doseAmerican Journal of Kidney Diseases, 1999
- Clinical and echocardiographic disease in patients starting end-stage renal disease therapyKidney International, 1995
- Implications for Health Care PolicyJAMA, 1981